Measuring Gender in the Healthy Oregon Project

健康俄勒冈项目中的性别衡量

基本信息

  • 批准号:
    10794845
  • 负责人:
  • 金额:
    $ 16.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-13 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The sexual and gender minority (SGM) community (i.e., LGBTQ+) is vastly underrepresented in cancer research. As such, there are limited data on cancer-related health outcomes and inequities, and a lack of evidence-based approaches to improve health equity. Importantly, the SGM umbrella term encompasses a heterogenous population, but much work to date has either combined subgroups or failed to disaggregate transgender and gender diverse (TGD) individuals. As such, there is an even greater need to include TGD individuals in research, and to include meaningful and accurate assessment of gender identity in that research. The NIH has developed recommendations for improvements in clinical research to improve SGM health. These include improved and expanded collection of gender identity and sexual orientation data, attention to intersectionality, and community engagement to ensure cultural competence/humility. The proposed administrative supplement project follows these recommendations by engaging TGD participants in the process of creating gender measurement items, testing the new measures in a large existing cohort, and conducting descriptive analyses to inform future research. The primary aim of this project is to conduct a mixed-methods study to guide decisions about terminology used for assessing gender within the Healthy Oregon Project (HOP). Much progress has been made toward improvement in and implementation of gender measurement, but persistent challenges remain. More specifically, current recommendations for language/terminology and response options used may not adequately and inclusively capture gender or the fluidity of gender identity. Such issues can lead to systemic gender miscategorization and low response rates in research, as well as contribute to discomfort and feelings of exclusion among TGD individuals. With the goal of improved and inclusive gender measurement, we propose to identify and test assessment items through an iterative process of individual interviews, focus groups, survey implementation in a large community cohort, and consultation with community stakeholders regarding results and recommendations. This work will add novel data to the extensive data already collected through HOP on health behaviors and cancer screening. In addition, the proposed supplement will facilitate improved data collection across the parent study cohorts that are recruited through HOP and provide a valuable opportunity to address important future questions regarding possible differences in follow on screening and prevention behaviors among TGD individuals who carry an HBOC or Lynch mutation. More broadly, the results will contribute to the expanded collection of valid gender identity data, the inclusion of TGD-specific data in research, and the improved assessment of cancer outcomes and health disparities for TGD communities.
项目摘要 性和性别少数群体(SGM)社区(即,LGBTQ+)在癌症中的代表性大大不足 research.因此,关于癌症相关健康结果和不平等的数据有限, 以证据为基础的方法来改善卫生公平。重要的是,SGM总括术语包括 异质人口,但迄今为止的许多工作要么结合了亚组,要么未能分解 跨性别和性别多样性(TGD)个体。因此,更有必要将TGD包括在内 研究中的个人,并在该研究中包括对性别认同的有意义和准确的评估。 美国国立卫生研究院已经制定了改善临床研究的建议,以改善SGM的健康。这些 包括改进和扩大性别认同和性取向数据收集,注意 交叉性和社区参与,以确保文化能力/谦逊。拟议 行政补充项目遵循这些建议, 创建性别计量项目的过程,在现有的大型群组中测试新的计量方法,以及 进行描述性分析,为未来的研究提供信息。该项目的主要目的是开展一项 混合方法研究,以指导决定用于评估卫生保健系统内性别问题的术语 俄勒冈州项目。在改善和执行性别平等方面取得了很大进展, 衡量,但持续的挑战仍然存在。更具体地说, 使用的语言/术语和回答选项可能无法充分和全面地反映性别或 性别认同的流动性。这些问题可能导致系统性的性别错误分类和低答复率 在研究中,以及有助于TGD个体之间的不适和排斥感。目标 为了改进和包容性的性别衡量,我们建议通过一个 个人访谈、焦点小组、在大型社区队列中实施调查的迭代过程, 并就结果和建议与社区利益攸关方进行磋商。这项工作将增加 新的数据已经通过HOP收集了大量关于健康行为和癌症筛查的数据。在 此外,拟议补充材料将有助于改善母研究队列的数据收集, 通过HOP招募,并提供了一个宝贵的机会,以解决未来的重要问题, TGD患者中携带TGD基因的个体在后续筛查和预防行为方面可能存在差异, HBOC或林奇突变。更广泛地说,这些结果将有助于扩大有效性别的收集, 身份数据,在研究中纳入TGD特异性数据,以及改善癌症结局评估 以及TGD社区的健康差异。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JACKILEN SHANNON其他文献

JACKILEN SHANNON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JACKILEN SHANNON', 18)}}的其他基金

THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO-COST EXTENSION TO THE PERIOD OF PERFORMANCE.
此修改的目的是免费延长履行期限。
  • 批准号:
    10462228
  • 财政年份:
    2021
  • 资助金额:
    $ 16.16万
  • 项目类别:
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression
萝卜硫素:膳食 HDAC 抑制剂和预防 DCIS 进展
  • 批准号:
    8019442
  • 财政年份:
    2009
  • 资助金额:
    $ 16.16万
  • 项目类别:
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression
萝卜硫素:膳食 HDAC 抑制剂和预防 DCIS 进展
  • 批准号:
    7588377
  • 财政年份:
    2009
  • 资助金额:
    $ 16.16万
  • 项目类别:
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression
萝卜硫素:膳食 HDAC 抑制剂和预防 DCIS 进展
  • 批准号:
    7758352
  • 财政年份:
    2009
  • 资助金额:
    $ 16.16万
  • 项目类别:
EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
EGCG 和 Omega-3 脂肪酸对前列腺脂肪酸合酶活性的影响
  • 批准号:
    7212333
  • 财政年份:
    2006
  • 资助金额:
    $ 16.16万
  • 项目类别:
EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
EGCG 和 Omega-3 脂肪酸对前列腺脂肪酸合酶活性的影响
  • 批准号:
    7295775
  • 财政年份:
    2006
  • 资助金额:
    $ 16.16万
  • 项目类别:
EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
EGCG 和 Omega-3 脂肪酸对前列腺脂肪酸合酶活性的影响
  • 批准号:
    7478587
  • 财政年份:
    2006
  • 资助金额:
    $ 16.16万
  • 项目类别:
DIETARY FATTY ACID INTAKE, COX-2 EXPRESSION AND RISK OF PROSTATE CANCER
膳食脂肪酸摄入量、COX-2 表达和前列腺癌风险
  • 批准号:
    7206577
  • 财政年份:
    2005
  • 资助金额:
    $ 16.16万
  • 项目类别:
Diet and Prostate Cancer Risk
饮食与前列腺癌风险
  • 批准号:
    6794948
  • 财政年份:
    2003
  • 资助金额:
    $ 16.16万
  • 项目类别:
Diet and Prostate Cancer Risk
饮食与前列腺癌风险
  • 批准号:
    6576095
  • 财政年份:
    2003
  • 资助金额:
    $ 16.16万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 16.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了